- Home
- Hematology
- Evidence-Based BSH 2024 Guidelines for the Diagnosis and Management of Adult Aplastic Anemia
2mo3 min read
Medical Article
Overview The new 2024 BSH adult aplastic anemia guideline updates diagnosis by including molecular cytogenetics and high-sensitivity paroxysmal nocturnal hemoglobinuria (PNH) flow cytometry. It recommends Antithymocyte Globulin (ATG), cyclosporin, and eltrombopag as first-line treatment for severe cases. Hematopoietic stem cell transplantation (HSC

Evidence-Based BSH 2024 Guidelines for the Diagnosis and Management of Adult Aplastic Anemia
Similar Content

Pancytopenia, a rare presentation of hyperthyroidism
832 Reached2 Comments

FOURIER Trial: Efficacy of Evolocumab in Managing Cardiovascular Events
563 Reached3 Comments

Vildagliptin in Reducing Risk of Post-partum Diabetes
2386 Reached7 Comments4 Likes

Acute Renal Failure in Child Due to High Dose of Indomethacin
685 Reached6 Comments

NSCLC Treatment To Control Long-term Tumor Growth
216 Reached1 Comments
